Hyundai Pharmaceutical Co., Ltd.
Hyundai Pharmaceutical Co., Ltd. (KRX: 004310) is trading at ₩7,760.00, about ₹560 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 5.02% today. Hyundai Pharmaceutical is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩7,720.00
Today's high
₩8,240.00
52 week low
₩3,500.00
52 week high
₩15,960.00
004310 opened at ₩8,150.00, closed previously at ₩8,170.00, and has traded between ₩3,500.00 and ₩15,960.00 over the past 52 weeks.
About
Headquartered in Seoul, South Korea, Hyundai Pharmaceutical Co., Ltd. is an international manufacturer and distributor of a diverse portfolio that includes pharmaceutical products, health food beverages, and medical equipment. The company's extensive offerings comprise both prescription (ETC) and over-the-counter (OTC) remedies, addressing a broad spectrum of therapeutic areas. These encompass conditions related to cardiovascular health, infectious diseases, the central nervous system, pain management, respiratory ailments, dermatological issues, digestive and endocrine system disorders, gynecological health, and ophthalmic care. Additionally, their range extends to nutritional supplements, diagnostic reagents, wound healing solutions, and treatments for allergies, arthritis, and anemia, among many others. The company was founded in 1965.
Key statistics
Avg. volume
5.18M
Market cap
₩181.97B
P/E Ratio
47.65
Price-to-sales ratio
0.90
Enterprise value
₩143.35B
Free cash flow yield
-4.94%
Debt-to-equity ratio
0.39
Return on equity
3.06%
ROIC
2.36%
Beta
0.70
Dividend yield
0.39%
Last dividend
₩30.00
Financial overview
Revenue
₩191.79B
Earnings per share
₩96.28
Free cash flow
-₩4.73B
Net profit margin
2.20%
Gross margin
35.83%
EBITDA
₩7.58B
Revenue growth
9.14%
Similar securities
This is not an investment recommendation
Hyundai Pharmaceutical for Indian investors
Hyundai Pharmaceutical is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Hyundai Pharmaceutical for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Hyundai Pharmaceutical’s current yield is 0.39%.Dividend tax explained
FAQs
Can I buy Hyundai Pharmaceutical on Paasa?
Hyundai Pharmaceutical (004310) has been listed on the Korea Exchange since 2000, in the Drug Manufacturers - Specialty & Generic industry. Hyundai Pharmaceutical is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Hyundai Pharmaceutical share cost in rupees?
One Hyundai Pharmaceutical share is ₩7,760.00 — about ₹560 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Hyundai Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Hyundai Pharmaceutical shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Hyundai Pharmaceutical price.
Does Hyundai Pharmaceutical pay a dividend, and how is it taxed in India?
Yes. Hyundai Pharmaceutical pays a dividend and the current yield is 0.39%; the last declared dividend was ₩30.00 per share, about ₹2.17. Dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare Hyundai Pharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Hyundai Pharmaceutical?
Yes. Hyundai Pharmaceutical is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.